financetom
Business
financetom
/
Business
/
Air-conditioner firm Carrier trims forecasts as residential demand wilts
News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities
Air-conditioner firm Carrier trims forecasts as residential demand wilts
Oct 28, 2025 8:40 AM

(Reuters) -Carrier Global ( CARR ) lowered its 2025 sales and profit forecasts on Tuesday, as it faces weak demand for heating, ventilation and air-conditioning products from residential markets.

It also announced a buyback of up to $5 billion, sending its shares up 2.6% in early morning trading.

Carrier's sales in the Americas from residential markets fell 30% in the third quarter, as distributors cleared out bloated inventory levels.

A slump in the North American housing market, largely due to stubbornly high mortgage rates and a surge in home prices, has hurt demand for heating and ventilation.

Despite a slight easing in mortgage rates after the Federal Reserve cut interest rates in September, an uncertain economic outlook and tepid hiring are keeping prospective homebuyers on the sidelines.

"We are of the view that demand will not recover in earnest until rates come down materially and a new housing market inflects up - including more sales of existing homes," said Scott Davis, analyst at Melius Research.

Slowing residential sales were partially offset by commercial customers such as data centers that use Carrier's products to cool down IT servers powering artificial intelligence technologies.

Carrier expects full-year net sales of about $22 billion, compared with its earlier forecast of about $23 billion. It forecast 2025 adjusted profit per share of roughly $2.65, compared with $3 to $3.10 estimated earlier.

The Florida-based company reported a third-quarter adjusted net income of 67 cents per share, compared with analysts' expectations of 57 cents, per data compiled by LSEG.

(Reporting by Anshuman Tripathy and Aishwarya Jain in Bengaluru; Editing by Mrigank Dhaniwala and Devika Syamnath)

Comments
Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.
Sign up to post
Sort by
Show More Comments
Related Articles >
Blackstone Says to Invest $1.2 Billion in West Virginia Power Generation Facility
Blackstone Says to Invest $1.2 Billion in West Virginia Power Generation Facility
Nov 13, 2025
10:26 AM EST, 11/13/2025 (MT Newswires) -- Blackstone (BX) said Thursday it will invest $1.2 billion to build a 600-megawatt power generation facility in Harrison County, West Virginia, through funds affiliated with Blackstone Energy Transition Partners. The Wolf Summit Energy facility, a fully contracted combined-cycle gas turbine power generation plant, will support growing local electricity demand, including from data centers,...
Form 8.3
Form 8.3
Nov 13, 2025
LONDON--(BUSINESS WIRE)--   FORM 8.3 PUBLIC OPENING POSITION DISCLOSURE/DEALING DISCLOSURE BY A PERSON WITH INTERESTS IN RELEVANT SECURITIES REPRESENTING 1% OR MORE Rule 8.3 of the Takeover Code (the “Code”) 1. KEY INFORMATION (a) Full name of discloser:   Millennium International Management LP (b) Owner or controller of interests and short positions disclosed, if different from 1(a): The naming of...
NRC Health Enters Partnership With BJC Healthcare to Improve Patient Experiences
NRC Health Enters Partnership With BJC Healthcare to Improve Patient Experiences
Nov 13, 2025
10:28 AM EST, 11/13/2025 (MT Newswires) -- NRC Health (NRC) said Thursday it has entered a partnership with BJC Health System to help improve patient experiences across its hospitals and clinics. Through the partnership NRC said it will provide its Patient Experience, Leader, and Employee Rounding offerings to create a consistent, data-driven foundation for improvement and connection across all sites...
US FDA approves Kura Oncology's blood cancer therapy
US FDA approves Kura Oncology's blood cancer therapy
Nov 13, 2025
Nov 13 (Reuters) - The U.S. Food and Drug Administration has approved Kura Oncology's ( KURA ) drug to treat a rare form of blood cancer that has returned or resisted initial therapy, the regulator said on Thursday. ...
Copyright 2023-2026 - www.financetom.com All Rights Reserved